Literature DB >> 15157567

Autoimmune polyglandular syndrome type 1 and the autoimmune regulator.

Qing-Guo Ruan1, Jin-Xiong She.   

Abstract

The autoimmune polyglandular syndrome type I (APSI) is an auto-somal recessive disorder that is characterized by chronic mucocutaneous candidiasis, multiple autoimmune endocrinopathies, and ectodermal dystrophies. The gene that is responsible for APSI has been identified as autoimmune regulator (AIRE). More than 50 different mutations have been discovered in patients who have APSI and the defects include nonsense and missense mutations, small insertions and deletions that lead to frameshift, and splice site mutations. The 545-amino acid protein that is encoded by AIRE contains several structural motifs that are suggestive of a transcriptional regulator. We provide an overview of the clinical and genetic features ofAPSI as well as the structure and functions of the AIRE protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157567     DOI: 10.1016/j.cll.2004.01.008

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  3 in total

Review 1.  PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Authors:  Lindsey A Baker; C David Allis; Gang G Wang
Journal:  Mutat Res       Date:  2008-07-17       Impact factor: 2.433

2.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire.

Authors:  Maureen A Su; Karen Giang; Kristina Zumer; Huimin Jiang; Irena Oven; John L Rinn; Jason J Devoss; Kellsey P A Johannes; Wen Lu; James Gardner; Angela Chang; Paula Bubulya; Howard Y Chang; B Matija Peterlin; Mark S Anderson
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

3.  Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.

Authors:  Anthony Meager; Kumuthini Visvalingam; Pärt Peterson; Kaidi Möll; Astrid Murumägi; Kai Krohn; Petra Eskelin; Jaakko Perheentupa; Eystein Husebye; Yoshihisa Kadota; Nick Willcox
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.